BACKGROUND: The effects of serum vitamin D status on atopy, steroid requirement, and functional responsiveness to corticosteroids in children versus adults with asthma have not been studied systematically. OBJECTIVE: We sought to explore the age-specific effects of vitamin D in asthmatic patients. METHODS: Serum vitamin D levels were examined in a prospective study of adults and children (102 healthy control subjects and 103 asthmatic patients). PBMCs were cultured for 3 hours with or without 100 nmol/L dexamethasone, and the expression of corticosteroid-regulated genes was detected by using real-time PCR. Serum IgE levels were measured, and information about asthmatic patients' steroid requirements was collected. RESULTS: Deficient serum vitamin D levels (<20 ng/mL) were found in 47.6% of asthmatic patients and 56.8% of healthy control subjects, with means ± SDs of 20.7 ± 9.8 and 19.2 ± 7.7 ng/mL, respectively. In multivariate regression models a significant positive correlation between serum vitamin D levels and the expression of vitamin D-regulated targets, cytochrome P450, family 24, subfamily a (cyp24a) expression by PBMCs (P = .0084, pediatric asthma group only) and serum LL-37 levels (P = .0006 in the pediatric group but P = .0067 in the adult asthma group), was found. An inverse association between vitamin D and serum IgE levels was observed in the pediatric (P = .006) asthma group. Serum vitamin D level (P = .05), as well as PBMC cyp24a expression (P = .0312), demonstrated a significant inverse relationship with daily inhaled corticosteroid dose in the pediatric asthma group only. Cyp24a expression in PBMCs correlated positively with in vitro suppression of TNF-α by dexamethasone (P = .05) and IL-13 (P = .0094) in PBMCs in the pediatric asthma group only. CONCLUSIONS: This study demonstrated significant associations between serum vitamin D status and steroid requirement and in vitro responsiveness to corticosteroids in the pediatric but not the adult asthma group. Vitamin D was also related to IgE levels in children but not in adults.
BACKGROUND: The effects of serum vitamin D status on atopy, steroid requirement, and functional responsiveness to corticosteroids in children versus adults with asthma have not been studied systematically. OBJECTIVE: We sought to explore the age-specific effects of vitamin D in asthmatic patients. METHODS: Serum vitamin D levels were examined in a prospective study of adults and children (102 healthy control subjects and 103 asthmatic patients). PBMCs were cultured for 3 hours with or without 100 nmol/L dexamethasone, and the expression of corticosteroid-regulated genes was detected by using real-time PCR. Serum IgE levels were measured, and information about asthmatic patients' steroid requirements was collected. RESULTS: Deficient serum vitamin D levels (<20 ng/mL) were found in 47.6% of asthmatic patients and 56.8% of healthy control subjects, with means ± SDs of 20.7 ± 9.8 and 19.2 ± 7.7 ng/mL, respectively. In multivariate regression models a significant positive correlation between serum vitamin D levels and the expression of vitamin D-regulated targets, cytochrome P450, family 24, subfamily a (cyp24a) expression by PBMCs (P = .0084, pediatric asthma group only) and serum LL-37 levels (P = .0006 in the pediatric group but P = .0067 in the adult asthma group), was found. An inverse association between vitamin D and serum IgE levels was observed in the pediatric (P = .006) asthma group. Serum vitamin D level (P = .05), as well as PBMC cyp24a expression (P = .0312), demonstrated a significant inverse relationship with daily inhaled corticosteroid dose in the pediatric asthma group only. Cyp24a expression in PBMCs correlated positively with in vitro suppression of TNF-α by dexamethasone (P = .05) and IL-13 (P = .0094) in PBMCs in the pediatric asthma group only. CONCLUSIONS: This study demonstrated significant associations between serum vitamin D status and steroid requirement and in vitro responsiveness to corticosteroids in the pediatric but not the adult asthma group. Vitamin D was also related to IgE levels in children but not in adults.
Authors: John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: Maria A Slack; Princess U Ogbogu; Gary Phillips; Thomas A E Platts-Mills; Elizabeth A Erwin Journal: Ann Allergy Asthma Immunol Date: 2015-05-21 Impact factor: 6.347
Authors: Kwok-Ho Yip; Natasha Kolesnikoff; Chunping Yu; Nicholas Hauschild; Houng Taing; Lisa Biggs; David Goltzman; Philip A Gregory; Paul H Anderson; Michael S Samuel; Stephen J Galli; Angel F Lopez; Michele A Grimbaldeston Journal: J Allergy Clin Immunol Date: 2014-01-22 Impact factor: 10.793
Authors: Yueh-Ying Han; Josh Blatter; John M Brehm; Erick Forno; Augusto A Litonjua; Juan C Celedón Journal: Lancet Respir Med Date: 2013-07-31 Impact factor: 30.700
Authors: Peter J Gergen; Stephen J Teach; Herman E Mitchell; Robert F Freishtat; Agustin Calatroni; Elizabeth Matsui; Meyer Kattan; Gordon R Bloomberg; Andrew H Liu; Carolyn Kercsmar; George O'Connor; Jacqueline Pongracic; Yadira Rivera-Sanchez; Wayne J Morgan; Christine A Sorkness; Neil Binkley; William Busse Journal: Am J Clin Nutr Date: 2013-04-17 Impact factor: 7.045